Managed a high performing team of eight account managers to enhance patient and clinical outcomes by providing solutions for medication preparation and administration. We are working hard to eliminate complications, reduce cost, improve safety for patients and healthcare professionals, and enable access to high quality care.

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care.Engaging with hospital executives and Government Health Departments, I supported key stakeholders to achieve organizational patient care, safety, and quality objectives. BD technologies help improve workflow efficiency, reduce costs, and prevent medication errors at all points of care throughout the hospital and delivery network. Additionally, BD has clinically differentiated patient diagnosis and care offerings supporting a variety of therapy areas.

Guidehouse Acquired Navigant in October 2019.Navigant's Global Life Sciences Practice provides a full spectrum of expertise to support product development and commercialization in Pharmaceutical, Specialty Pharmaceutical, and Medical Device, and Medical Data and Technology:- Business Development: Market and product assessment, Value and due diligence, In-licensing and partnership support, Financial modeling- Market Access: KOL and payer value proposition alignment, Value story development, Global and regional pricing strategies, Reimbursement and contracting strategy- Marketing Planning: Marketing planning systems to support global and regional teams, Product launch planning and strategy development- Brand and Portfolio Strategy and New Product Planning: Buying process and patient flow analysis, Product opportunity assessment, Clinical development planning, Product positioning, Lifecycle management strategy, Franchise planning and Innovation processOffices located in Boston, Chicago, Dallas, Los Angeles, New York, Princeton, San Francisco, London, and Berlin.

Business Manager for new Vascular Division launched in the US in 2016. Responsible for facilitating internal and external activities required for successful launch of the new Vascular Business Unit in the US, helping drive growth for BIOTRONIK Vascular Intervention globally.- Secured BIOTRONIK’s first U.S. vascular revenue by sourcing and executing a distribution agreement for the peripheral product portfolio, leading negotiations on transfer pricing and sales volumes; managed this strategic partnership and was responsible for meeting revenue targets- Developed and received approval for the go-to-market plan for BIOTRONIK Vascular Intervention in the U.S., including the sales structure, commission rates, and definition of the future product portfolio- Engaged clinical investigators to drive clinical enrollment by describing the global BIOTRONIK organization and communicating the U.S. strategic plan

- Managed products within the coronary and peripheral vascular portfolios that generated more than €45,000,000 in annual revenue, including strategy development and execution- Responsible for regions including Asia-PAC/Australia (subsidiaries and distributors within BIOTRONIK’s fastest growing market), the UK and Italy (experience with mature country organizations), and the US (managing products through 510(k) and PMA approval) – which provided a well-developed understanding of global markets and commercial and clinical contacts throughout these regions- Built a network of KOL physician contacts and to gain voice of customer input for new technologies that were included in the user needs and helped assess the potential market

- Developed the HemoShear business plan which won access to the Darden Business Incubator and finished 3rd in the Darden Business Plan Competition- Developed the five-year financial model to be used for planning and valuation purposes; model used by executive team to raise an initial $4MM in investment funding- Quantified and communicated the value proposition in company sales presentation that resulted in the first $30K contract and three potential contracts ranging from $100K-$1MM

- Led cross-functional teams to develop medical devices from concept to regulatory approval - Evaluated device intellectual property landscape and worked with company Co-Founder to design and test next generation device prototypes that expanded the product pipeline